Literature DB >> 25382732

Cancer stem cell division: when the rules of asymmetry are broken.

Subhas Mukherjee1, Jun Kong, Daniel J Brat.   

Abstract

Asymmetric division of stem cells is a highly conserved and tightly regulated process by which a single stem cell produces two daughter cells and simultaneously directs the differential fate of both: one retains its stem cell identity while the other becomes specialized and loses stem cell properties. Coordinating these events requires control over numerous intra- and extracellular biological processes and signaling networks. In the initial stages, critical events include the compartmentalization of fate determining proteins within the mother cell and their subsequent passage to the appropriate daughter cell. Disturbance of these events results in an altered dynamic of self-renewing and differentiation within the cell population, which is highly relevant to the growth and progression of cancer. Other critical events include proper asymmetric spindle assembly, extrinsic regulation through micro-environmental cues, and noncanonical signaling networks that impact cell division and fate determination. In this review, we discuss mechanisms that maintain the delicate balance of asymmetric cell division in normal tissues and describe the current understanding how some of these mechanisms are deregulated in cancer. The universe is asymmetric and I am persuaded that life, as it is known to us, is a direct result of the asymmetry of the universe or of its indirect consequences. The universe is asymmetric. -Louis Pasteur.

Entities:  

Mesh:

Year:  2014        PMID: 25382732      PMCID: PMC4313409          DOI: 10.1089/scd.2014.0442

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  79 in total

1.  Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.

Authors:  Jun Yang; Wen Zhang; Paul M Evans; Xi Chen; Xi He; Chunming Liu
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

2.  Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster.

Authors:  Emmanuel Caussinus; Cayetano Gonzalez
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

Review 3.  Notch signaling in the regulation of stem cell self-renewal and differentiation.

Authors:  Jianing Liu; Chihiro Sato; Massimiliano Cerletti; Amy Wagers
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

4.  Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells.

Authors:  Joerg Betschinger; Karl Mechtler; Juergen A Knoblich
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.

Authors:  Alicia M Viloria-Petit; Laurent David; Jun Yong Jia; Tuba Erdemir; Anita L Bane; Dushanthi Pinnaduwage; Luba Roncari; Masahiro Narimatsu; Rohit Bose; Jason Moffat; John W Wong; Robert S Kerbel; Frances P O'Malley; Irene L Andrulis; Jeffrey L Wrana
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

Review 6.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

Review 7.  Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer.

Authors:  Ralph A Neumüller; Juergen A Knoblich
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

8.  Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.

Authors:  H Zheng; H Ying; H Yan; A C Kimmelman; D J Hiller; A-J Chen; S R Perry; G Tonon; G C Chu; Z Ding; J M Stommel; K L Dunn; R Wiedemeyer; M J You; C Brennan; Y A Wang; K L Ligon; W H Wong; L Chin; R A dePinho
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-01-15

9.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Authors:  Martin Peifer; Lynnette Fernández-Cuesta; Martin L Sos; Julie George; Danila Seidel; Lawryn H Kasper; Dennis Plenker; Frauke Leenders; Ruping Sun; Thomas Zander; Roopika Menon; Mirjam Koker; Ilona Dahmen; Christian Müller; Vincenzo Di Cerbo; Hans-Ulrich Schildhaus; Janine Altmüller; Ingelore Baessmann; Christian Becker; Bram de Wilde; Jo Vandesompele; Diana Böhm; Sascha Ansén; Franziska Gabler; Ines Wilkening; Stefanie Heynck; Johannes M Heuckmann; Xin Lu; Scott L Carter; Kristian Cibulskis; Shantanu Banerji; Gad Getz; Kwon-Sik Park; Daniel Rauh; Christian Grütter; Matthias Fischer; Laura Pasqualucci; Gavin Wright; Zoe Wainer; Prudence Russell; Iver Petersen; Yuan Chen; Erich Stoelben; Corinna Ludwig; Philipp Schnabel; Hans Hoffmann; Thomas Muley; Michael Brockmann; Walburga Engel-Riedel; Lucia A Muscarella; Vito M Fazio; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle A M Heideman; Peter J F Snijders; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; John Field; Steinar Solberg; Odd Terje Brustugun; Marius Lund-Iversen; Jörg Sänger; Joachim H Clement; Alex Soltermann; Holger Moch; Walter Weder; Benjamin Solomon; Jean-Charles Soria; Pierre Validire; Benjamin Besse; Elisabeth Brambilla; Christian Brambilla; Sylvie Lantuejoul; Philippe Lorimier; Peter M Schneider; Michael Hallek; William Pao; Matthew Meyerson; Julien Sage; Jay Shendure; Robert Schneider; Reinhard Büttner; Jürgen Wolf; Peter Nürnberg; Sven Perner; Lukas C Heukamp; Paul K Brindle; Stefan Haas; Roman K Thomas
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

10.  TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1.).

Authors:  Y Liu; R Raheja; N Yeh; D Ciznadija; A M Pedraza; T Ozawa; E Hukkelhoven; H Erdjument-Bromage; P Tempst; N P Gauthier; C Brennan; E C Holland; A Koff
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more
  19 in total

1.  Stem cells: Asymmetric rejuvenation.

Authors:  Anu Suomalainen
Journal:  Nature       Date:  2015-05-21       Impact factor: 49.962

2.  Drosophila Brat and Human Ortholog TRIM3 Maintain Stem Cell Equilibrium and Suppress Brain Tumorigenesis by Attenuating Notch Nuclear Transport.

Authors:  Subhas Mukherjee; Carol Tucker-Burden; Changming Zhang; Kenneth Moberg; Renee Read; Costas Hadjipanayis; Daniel J Brat
Journal:  Cancer Res       Date:  2016-02-18       Impact factor: 12.701

Review 3.  Understanding pancreatic cancer stem cells and their role in carcinogenesis: a narrative review.

Authors:  Vikram Sumbly; Ian Landry
Journal:  Stem Cell Investig       Date:  2022-01-19

Review 4.  Off the Clock: the Non-canonical Roles of Cyclin-Dependent Kinases in Neural and Glioma Stem Cell Self-Renewal.

Authors:  Ling-Kai Shih; Subhas Mukherjee; Daniel J Brat
Journal:  Mol Neurobiol       Date:  2022-08-31       Impact factor: 5.682

5.  Matrix Stiffness Modulates Mesenchymal Stem Cell Sensitivity to Geometric Asymmetry Signals.

Authors:  Maria E Piroli; Ehsan Jabbarzadeh
Journal:  Ann Biomed Eng       Date:  2018-03-14       Impact factor: 3.934

Review 6.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

Review 7.  Polarity as a physiological modulator of cell function.

Authors:  Maria E Piroli; James O Blanchette; Ehsan Jabbarzadeh
Journal:  Front Biosci (Landmark Ed)       Date:  2019-01-01

8.  Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line.

Authors:  Phyllis F Y Cheung; Chi Wai Yip; Linda W C Ng; Kwok Wai Lo; Chit Chow; Kui Fat Chan; Tan To Cheung; Siu Tim Cheung
Journal:  Cancer Cell Int       Date:  2016-06-08       Impact factor: 5.722

9.  Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.

Authors:  Gina Lee; Robert R Hall; Atique U Ahmed
Journal:  J Stem Cell Res Ther       Date:  2016-10-26

10.  Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.

Authors:  Puteri Baharuddin; Nazilah Satar; Kamal Shaik Fakiruddin; Norashikin Zakaria; Moon Nian Lim; Narazah Mohd Yusoff; Zubaidah Zakaria; Badrul Hisham Yahaya
Journal:  Oncol Rep       Date:  2015-11-02       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.